what's Metanova Labs?
Metanova Labs is a crypto-native biotech company pioneering decentralized drug discovery. They leverage AI and blockchain incentives to develop next-generation therapeutics targeting mental states and critical biological processes. Through their NOVA platform on the Bittensor network (subnet 68), Metanova enables permissionless global competitions where AI models screen over 65 billion molecules. This adversarial system accelerates hit identification, with validated results like HDAC inhibitors and partnerships for wet-lab testing.
Metanova Labs, a Bittensor subnet, was featured by Khala Research for traction and product-market fit.
Links
x.com/metanova_labsFeatured in Khala Research's first Bittensor report as one of five subnets demonstrating traction and real-world product-market fit.
The project carries a $10 million valuation as a Bittensor subnet, one of the lowest among listed competitors in the ecosystem.
First winning code on NOVA_Blueprint delivers 418% improvement metric.
NOVA_Blueprint goes live as a winner-takes-all competitive system where miners compete every 24 hours to build chemical search algorithms, with only winners receiving alpha token rewards.